about
Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant?Transfer of Maternal Immune Cells by Breastfeeding: Maternal Cytotoxic T Lymphocytes Present in Breast Milk Localize in the Peyer's Patches of the Nursed InfantGag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study.Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality.PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years.HIV-1 proteins, Tat and gp120, target the developing dopamine systemGag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational StudySimple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo.Nutritional and Immunological Correlates of Memory and Neurocognitive Development Among HIV-Infected Children Living in Kayunga, Uganda.IL-8 Alterations in HIV-1 Infected Children With Disease Progression.Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in VietnamDichotomy between T Cell and B Cell Tolerance to Neonatal Retroviral Infection Permits T Cell Therapy.Immunological correlates of behavioral problems in school-aged children living with HIV in Kayunga, UgandaMaternal HIV infection influences the microbiome of HIV-uninfected infants.CD4 Decay Rate as an Indicator of the Time Interval between Initial Infection and First Diagnosis among Drug-Naïve Human Immunodeficiency Virus Seropositive Individuals in Lagos, Nigeria.CNS Impact of Perinatal HIV Infection and Early Treatment: the Need for Behavioral Rehabilitative Interventions Along with Medical Treatment and Care.The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysisCritical Role for Monocytes/Macrophages in Rapid Progression to AIDS in Pediatric Simian Immunodeficiency Virus-Infected Rhesus Macaques.Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.Are infants unique in their ability to be "functionally cured" of HIV-1?Impact of Clinical Parameters in the Intrahost Evolution of HIV-1 Subtype B in Pediatric Patients: A Machine Learning ApproachEmbracing the complexity of HIV immunology.Alterations in B Cell Compartment Correlate with Poor Neutralization Response and Disease Progression in HIV-1 Infected Children.Role of Monocyte/Macrophages during HIV/SIV Infection in Adult and Pediatric Acquired Immune Deficiency Syndrome.The pharmacological treatment of acute HIV infections in neonates.Pregnancy and infection: using disease pathogenesis to inform vaccine strategy.Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.Altered Toll-Like Receptor-4 Response to Lipopolysaccharides in Infants Exposed to HIV-1 and Its Preventive Therapy.HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South AfricaBroadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
P2860
Q27008774-3FA3172E-9250-44BF-ABF7-F76CEDD5F3CCQ27342091-31D669E2-4CC1-4C1B-A013-4B8AB36B70D6Q33629212-ACE5507E-F6DA-4D03-8089-FCE10A854778Q34196888-865CA3D8-C325-4A33-B607-9B606379AF48Q35352866-4DB000CD-CE30-46C1-9F4C-74DA9F8FEB76Q35722000-8E55A149-4316-461D-A9AD-2D78C1B04E07Q35743630-9392B04F-27A4-48B0-8B3D-86DE7E3BDFA7Q35864285-C30A1F45-F7F8-4BF2-A5F5-B160E8F3F17EQ35991165-AF077128-D873-4ED0-AE56-E2D8638CB073Q36504397-DD38DC05-EC77-4912-81CB-1AE6B1DA1F60Q36677919-367E58C3-11ED-4AD5-87C8-413F9689F6F5Q36992913-11422A8A-8C47-4DDD-BBD2-1C2B72784886Q37209955-66B637F7-2D72-4EE8-9D5D-D0469DCEFB3EQ37355615-DCB2B960-B643-425D-AC21-4E2F6D48F5AEQ37609359-0D0A3C4B-4637-45B4-8F65-C631E3EE9173Q37635172-468D92EA-6BB6-4C9B-984C-176B5082598FQ38405864-F91820D7-9C2B-4B0E-A7E2-7AB5F260690BQ38991265-7E0B82EE-5C87-41D6-8366-2E3F347264A5Q39003366-1ED90C1A-EA0B-4977-BA96-A4C7A8750AEFQ39496551-EE13060A-8938-4FB3-995E-EA9AB7F7CAA0Q40178574-26CAE831-DC4C-4C28-9392-D20A08F1A2A5Q40458484-EDDE77CC-97EF-40FE-8C72-DCD8623DBA04Q42234163-724D2982-5050-4C71-B2FE-44B14022D571Q42675473-43AC1E22-A1A3-4690-AEEC-B746CF41E3A7Q46770038-04FCC3A9-7CB7-4BD6-8B9E-5DB5673C15DFQ47094547-A242FC78-3A2A-41B2-9A74-A68F8A8093FBQ47100536-2588A6FE-8A24-4ABB-848E-1ADE41B23D0FQ47591909-28C86B1B-B2E4-4C94-85B2-46B99E1B0F35Q48504993-63729AA0-2030-4D21-9E05-A86914A77E5BQ52577900-78E327E8-F56A-4F2E-834B-65668AD007FAQ52591828-D5A79B6C-8888-4BB7-A2D4-06CD25032999Q52680555-95AD47CE-E93C-4B3E-81B4-34350A9C409DQ56938270-F5A86B65-793F-42FF-B9C2-E973A0B5BF89Q56974226-C4307920-4E4D-4EEF-B458-4B84BC30FC74
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunology of pediatric HIV infection
@en
Immunology of pediatric HIV infection.
@nl
type
label
Immunology of pediatric HIV infection
@en
Immunology of pediatric HIV infection.
@nl
prefLabel
Immunology of pediatric HIV infection
@en
Immunology of pediatric HIV infection.
@nl
P2860
P356
P1476
Immunology of pediatric HIV infection
@en
P2093
Grace M Aldrovandi
Nicole H Tobin
P2860
P304
P356
10.1111/IMR.12074
P577
2013-07-01T00:00:00Z